Find a news story anywhere in the world:

Category:    

Keywords:   

Address:    
   
Stories Stories Health AB Science loses appeal over EU rejection of cancer drug

AB Science loses appeal over EU rejection of cancer drug

http://mireportz.com/media/reviews/photos/thumbnail/300x300s/82/fb/67/13628-ab-science-loses-appeal-over-eu-rejection-of-cancer-drug-10-1400593724.gif
Written by Aldine      May 20, 2014    
 
0.0 (0)
518   0   3   0   0   0
 
Write Review
AB Science loses appeal over EU rejection of cancer drug.gif

French biotech company AB Science has lost an appeal to get the London-based European Medicines Agency to reconsider its rejection of the company's cancer drug Masican, originally handed down in November.

AB Science Loses appeal

AB Science had been seeking conditional authorization of the drug, also known as masitinib mesylate, for the second-line treatment of malignant gastrointestinal stromal tumor.

The company said it now intended to file for full approval with data from an ongoing confirmatory Phase III study.

[Read Full article: AB Science loses appeal over EU rejection of cancer drug]

AB Science loses appeal over EU rejection of cancer drug-2.jpg
AB Science loses appeal over EU rejection of cancer drug-1.jpg

Location

Epicentre
London,London,United Kingdom

Details

Author
Ben Hirschler
Contributor's Comment
French biotech company AB Science has lost an appeal.
Swap Start/End

User reviews

There are no user reviews for this listing.

 
Site sponsored by BiStuff | Buy & Sell Locally